The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.
* Patients who participate will be asked to complete detailed family and medical history questionnaires initially, with a follow-up questionnaire every year. * Patients will be asked to supply a blood sample and possibly a mouthwash sample, both of which can be done by mail. * Patients will be asked to consent to the release of their lymphoma tissue block for the purposes of the study. * Patients will be given letters of invitation for their affected relatives to invite them to participate.
Study Type
OBSERVATIONAL
Enrollment
1,500
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
RECRUITINGGenetic factors that contribute to the development of lymphomas and CLL
Genetic factors that contribute to the development of lymphomas and CLL
Time frame: Indefinite
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.